5,657
Views
2
CrossRef citations to date
0
Altmetric
Article

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

, , , , , , , & show all
Article: 2200866 | Received 15 Nov 2022, Accepted 01 Mar 2023, Published online: 27 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.